Sidebar Ads

Sunday, September 9, 2018

Roche faces UK pricing row over multiple sclerosis drug Ocrevus

Roche faces a fresh row over drug pricing in Britain, following a decision by the body responsible for medicine use within the state health service not to approve its drug Ocrevus for treating a highly disabling form of multiple sclerosis (MS).


from Reuters: Business News https://ift.tt/2CDx2m3

Related Posts:

0 comments:

Post a Comment

'I feel sick at the prospect of welfare cuts'

People on long-term sickness and disability benefits have told the BBC they fear how cuts will affect them. from BBC News https://ift.tt/2...